The Oncology Institute, Inc.TOIIWNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR-50.5%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-50.5%/yr
Quarterly compound
Percentile
P57
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 6.67% |
| Q2 2025 | 28.57% |
| Q1 2025 | -50.00% |
| Q4 2024 | 22.22% |
| Q3 2024 | -5.88% |
| Q2 2024 | 22.73% |
| Q1 2024 | -4.76% |
| Q4 2023 | -10.53% |
| Q3 2023 | 17.39% |
| Q2 2023 | 43.90% |
| Q1 2023 | -215.38% |
| Q4 2022 | -286.90% |
| Q3 2022 | 55.02% |
| Q2 2022 | -133.95% |
| Q1 2022 | 246.67% |
| Q4 2021 | -275.00% |
| Q3 2021 | -180.00% |
| Q2 2021 | 431.13% |
| Q1 2021 | 94.97% |
| Q4 2020 | -256.72% |
| Q3 2020 | -646.10% |
| Q2 2020 | 103.58% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |